Delivery Order SPE2DB25D3201-SPE2DB25FNSJV
Award Date
4/14/25
Potential Completion Date
5/5/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,953.30 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides 4567377135 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a period of performance through March 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,627.75 contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product, with a period of performance through February 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $10,987.05 contract is for the supply of LEQVIO 284 MG/1.5 ML syringes, a specialty pharmaceutical product, in support of military treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a firm fixed price and a ceiling value of $13,953.30, with a performance period through May 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Department of Defense (DoD) Medical Supply Chain (VPDLATSMED-A). The contract is for $10,987.05 and provides the DoD with the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award has an ultimate completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,976.65, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,651.10, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific business type. In addition to this delivery order,...
This is a firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $13,184.46, is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,953.30 firm fixed-price contract is for the delivery of 4567995177 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a performance period through May 13, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,282,894 units of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The $13,184.46 delivery order has a completion date of January 31, 2024. Amerisourcebergen Drug Corp has a longstanding relationship with DLA Troop Support Medical as a prime contractor providing pharmaceuticals, medical...